arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Vivani Medical, Inc.

VANI
$1.05 ▼ -0.02 (-2.33%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
52 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Vivani Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $91.4M
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC -28.6% →
FCF / Share $-0.07 ↗
Trailing P/E —
Price / Book 5.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

52-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-6.78M
↓ -7.6% —
Operating Margin Operating profit as % of sales
-380.5%
↑ +9.2% —
FCF / Share Free cash flow per share
$-0.07
↑ +7.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
4
Cash Quality ↓
63

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 52 quarters